8-K: SelectQuote Inc. Reports Strong Second Quarter Results and Raises Fiscal Year 2024 Guidance

SelectQuote, Inc. announced strong second quarter fiscal year 2024 results, exceeding expectations and raising full-year guidance across all key metrics.

Summary

• SelectQuote reported a revenue of $405.4 million for the second quarter of fiscal year 2024, a 27% increase compared to $319.2 million in the same quarter of the previous year.
• The company's net income for the quarter was $19.4 million, slightly down from $22.5 million in the prior year.
• Adjusted EBITDA for the quarter reached $67.4 million, up from $63.6 million in the second quarter of fiscal year 2023.
• SelectQuote is raising its fiscal year 2024 revenue guidance to a range of $1.23 billion to $1.3 billion, up from the previous range of $1.05 billion to $1.2 billion.
• The company now expects a net loss between $45 million and $22 million for fiscal year 2024, an improvement from the prior guidance of a $50 million to $22 million loss.
• Adjusted EBITDA for fiscal year 2024 is now projected to be between $90 million and $105 million, compared to the previous range of $80 million to $105 million.
• The Senior segment saw revenue of $247.5 million and Adjusted EBITDA of $78.7 million, with 234,576 approved Medicare Advantage policies.
• Healthcare Services revenue was $111.7 million with Adjusted EBITDA of $3.0 million, and SelectRx membership exceeded 62,000.
• The Life segment reported revenue of $37.4 million and Adjusted EBITDA of $4.6 million, while Auto & Home had revenue of $10.5 million and Adjusted EBITDA of $4.7 million.
• SelectQuote anticipates approaching positive free cash flow in fiscal year 2024.

Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to strong revenue growth, improved profitability, and raised guidance. The company's strategic initiatives appear to be yielding positive results, and the management's comments are optimistic.

Positives

• SelectQuote has shown strong revenue growth across all segments.
• The company has improved its profitability, with positive Adjusted EBITDA in multiple segments.
• The company is experiencing significant growth in its Healthcare Services segment, particularly with SelectRx.
• The company has raised its full-year guidance, indicating confidence in future performance.
• SelectQuote is approaching positive free cash flow, a significant milestone.
• The company's Senior segment continues to perform well with strong agent productivity and policyholder persistency.
• The revenue per approved policy has increased significantly, driven by pharmacy revenue.
• The company has achieved two consecutive quarters of positive operating cash flow on a last twelve months basis.

Negatives

• Net income for the second quarter of fiscal year 2024 decreased slightly compared to the same quarter of the previous year.
• The company is still projecting a net loss for the full fiscal year 2024, although the loss is expected to be smaller than previously anticipated.
• The Senior segment's Adjusted EBITDA decreased by 6% for the three months ended December 31, 2023, compared to the same period in 2022.
• The lifetime value of commissions per approved Dental, Vision and Hearing policy decreased by 41% for the three months ended December 31, 2023, compared to the same period in 2022.
• The lifetime value of commissions per approved Other policy decreased by 143% for the three months ended December 31, 2023, compared to the same period in 2022.

Risks

• The company relies on a limited number of insurance carrier partners, and the termination of these relationships could negatively impact the business.
• Changes in health insurance laws and regulations could affect the company's operations.
• Competition from other brokers and insurance carriers could impact market share.
• The company's financial results are subject to seasonality.
• The company's ability to maintain compliance with debt covenants is a risk.
• Cybersecurity breaches or other attacks could disrupt operations and compromise data.
• The company's pharmacy business is subject to risks including supply chain disruptions and regulatory changes.
• The company's ability to access additional capital on acceptable terms is a risk.

Future Outlook

SelectQuote has raised its fiscal year 2024 guidance, expecting revenue between $1.23 billion and $1.3 billion, a net loss between $45 million and $22 million, and Adjusted EBITDA between $90 million and $105 million. The company also anticipates approaching positive free cash flow in fiscal year 2024.

Management Comments

• Chief Executive Officer Tim Danker stated, 'The second quarter marked SelectQuotes eighth consecutive quarter of performance ahead of expectations, and we remain confident that our strategy to prioritize predictable and cash efficient growth will continue to generate value for both our customers and shareholders.'
• Mr. Danker continued, 'We are also pleased with our progress on operating cash flow and now anticipate that SelectQuote will approach positive free cash flow in fiscal 2024.'
• Mr. Danker also stated, 'We are pleased to increase our fiscal year 2024 outlook based on the strength of both businesses year-to-date.'

Industry Context

The results reflect a strong performance in the health insurance brokerage sector, particularly in the Medicare Advantage market, where SelectQuote has demonstrated significant growth. The expansion of their Healthcare Services segment, especially SelectRx, indicates a move towards integrated healthcare solutions, a growing trend in the industry.

Comparison to Industry Standards

• SelectQuote's revenue growth of 27% year-over-year is strong compared to industry averages for insurance brokers, which typically see single-digit growth.
• The company's Adjusted EBITDA margin of 16% per MA/MS policy for the twelve months ended December 31, 2023, is a significant improvement compared to 6% for the same period in 2022, indicating improved operational efficiency.
• Competitors like eHealth, Inc. (EHTH) and GoHealth, Inc. (GOCO) also operate in the health insurance brokerage space, but SelectQuote's focus on a diversified model including pharmacy services sets it apart.
• The growth in SelectRx membership to over 62,000 members is a positive sign, as many competitors do not have a pharmacy offering.
• The company's revenue to customer acquisition cost multiple of 4.2x is a strong indicator of efficient marketing spend compared to industry benchmarks.

Stakeholder Impact

• Shareholders will benefit from the increased revenue and improved profitability.
• Employees may benefit from the company's growth and success.
• Customers will have access to a wider range of insurance and healthcare services.
• Suppliers may see increased business opportunities due to the company's growth.
• Creditors may have increased confidence in the company's ability to meet its obligations.

Next Steps

• The company will host a conference call with the investment community on February 7, 2024.
• The company will continue to focus on predictable and cash-efficient growth.
• The company will continue to expand its SelectRx business and healthcare services offerings.

Key Dates

Keywords

SelectQuote, Insurance, Medicare Advantage, Healthcare Services, SelectRx, EBITDA, Financial Results, Revenue, Guidance, Pharmacy, Senior, Life, Auto & Home